Inter-strain tissue-infiltrating T cell responses to minor histocompatibility antigens involved in graft-versus-host disease as determined by Vβ spectratype analysis

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5352-5359

  Zilberberg, Jenny ^a   McElhaugh, Danielle ^a,b   Gichuru, Loise N ^a   Korngold, Robert ^a   Friedman, Thea M ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR; MINOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALB B MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CXB 2 MOUSE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; INTESTINE; LIVER; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE SUBPOPULATION; TISSUE INJURY; TISSUE SPECIFICITY; ANIMAL; COMPLEMENTARITY DETERMINING REGION; IMMUNOLOGY; METABOLISM;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; GRAFT VS HOST DISEASE; MICE; MICE, INBRED STRAINS; MINOR HISTOCOMPATIBILITY ANTIGENS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 45949103630     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5352     Document Type: Article

References (21)

1. Slavin, S., S. Morecki, L. Weiss, and R. Or. 2002. Donor lymphocyte infusion: the use of alloreactive and tumor-reactive lymphocytes for immunotherapy of malignant and nonmalignant diseases in conjunction with allogeneic stem cell transplantation. J. Hematother. Stem Cell Res. 11: 265-276.
2. Nash, R. A., and R. Storb. 1996. Graft-versus-host effect after allogeneic hematopoietic stem cell transplantation: GVHD and GVL. Curr. Opin. Immunol. 8: 674-680.
3. Shlomchik, W. D. 2007. Graft-versus-host disease. Nat. Rev. Immunol. 7: 340-352.
4. Martin, P. J., J. A. Hansen, B. Torok-Storb, L. Moretti, O. Press, R. Storb, E. D. Thomas, P. L. Weiden, and E. S. Vitetta. 1988. Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease. Bone Marrow Transplant. 3: 437-444.
5. Patterson, A. E., and R. Korngold. 2001. Infusion of select leukemia-reactive TCR V/3+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation. Biol. Blood Marrow Transplant. 7: 187-196.
6. Friedman, T. M., O. Azhipa, J. Zilberberg, Y. Tkachuk, J. W. Hsu, S. D. Rowley, S. L. Goldberg, R. Korngold, A. L. Pecora, and R. A. Preti. 2006. Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation. Biol. Blood Marrow Transplant. 12: 1092-1095.
7. + T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. J. Immunol. 161: 41-48.
8. + T- cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate. Biol. Blood Marrow Transplant. 7: 2-13.
9. Jones, S. C., T. M. Friedman, G. F. Murphy, and R. Korngold. 2004. Specific donor Vβ-associated CD4 T-cell responses correlate with severe acute graftversus-host disease directed to multiple minor histocompatibility antigens. Biol. Blood Marrow Transplant. 10: 91-105.
10. + T-cell repertoires during the development of graft-versus-host disease directed to minor histocompatibility antigens. Biol. Blood Marrow Transplant. 10: 224-235.
11. + T cell receptor Vβ repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens. J. Immunol. 159: 77-85.
12. Berger, M., P. J. Wettstein, and R. Korngold. 1994. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens. Transplantation 57: 1095-1102.
13. + T cells mediating graft-versus-host disease directed to minor histocompatibility antigens. Biol. Blood Marrow Transplant. 13: 265-276.
14. Murphy, G. F., H. Sueki, C. Teuscher, D. Whitaker, and R. Korngold. 1994. Role of mast cells in early epithelial target cell injury in experimental acute graftversus-host disease. J. Invest. Dermatol. 102: 451-461.
15. Kusser, K. L., and T. D. Randall. 2003. Simultaneous detection of EGFP and cell surface markers by fluorescence microscopy in lymphoid tissues. J. Histochem. Cyto Chem. 51: 5-14.
16. Griem, P., H. J. Wallny, K. Falk, O. Rotzschke, B. Arnold, G. Schonrich, G. Hammerling, and H. G. Rammensee. 1991. Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression. iCell 65: 633-640.
17. Rosset, M. B., V. Tieng, D. Charron, and A. Toubert. 2003. Differences in MHC- class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) mice. Clin. Exp. Immunol. 132: 46-52.
18. Korngold, R., and P. J. Wettstein. 1990. Immunodominance in the graft-vs-host disease T cell response to minor histocompatibility antigens. J. Immunol. 145: 4079-4088.
19. Gorski, J., M. Yassai, X. Zhu, B. Kissela, B. Kissella, C. Keever, and N. Flomenberg. 1994. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping: correlation with immune status. J. Immunol. 152: 5109-5119.
20. de Bueger, M., A. Bakker, J. J. Van Rood, F. Van der Woude, and E. Goulmy. 1992. Tissue distribution of human minor histocompatibility antigens: ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol. 149: 1788-1794.
21. Stuber, E., A. Von Freier, D. Marinescu, and U. R. Folsch. 1998. Involvement of OX40-OX40L interactions in the intestinal manifestations of the murine acute graft-versus-host disease. Gastroenterology 115: 1205-1215.